NEPH.US Nephros Inc

Healthcare Household Durables USA Stocks
3.05 USD
Close of Nov 15, 2026
2.66 6.42
Market cap
USD 33.2M
P/E
17.9x
P/B
2.64x
ROE
19.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NEPH.US undervalued?

Graham number
Price3.05
Graham value2.10
Premium45.1%

NEPH.US trades 45.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Nephros Inc fundamental analysis

No fundamental analysis for Nephros Inc yet.

Nephros Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Nephros Inc

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare …

Full company profile